Opening Plenary Session 1: Emerging Therapeutics for OA

Date/Time: Friday, March 17, 2023 - 1:45 PM to 3:30 PM
Log in to Add to My Schedule

Description:

Current Landscape of Regenerative Medicine Approaches in Osteoarthritis
Frank Barry 

When Neuro-Immune Communication Meets Arthritis
Kevin J. Tracey

Sponsored by Fidia

Abstract(s):

  • O-1
    INCREASED JOINT LOADING 1 MONTH AFTER PLATELETRICH
    PLASMA TREATMENT OF KNEE OA IS ASSOCIATED
    WITH IMPROVED CLINICAL OUTCOMES 2 YEARS LATER
    J. He1,2, J. C. Erhart-Hledik1,2, C. R. Chu1,2; 1Stanford Univ., Stanford, CA, 2VA
    Palo Alto Hlth.Care System, Palo Alto, CA

    O-2
    SAFETY AND PRELIMINARY EFFICACY OF PCRX201,
    AN INTRA-ARTICULAR GENE THERAPY FOR KNEE
    OSTEOARTHRITIS: A PHASE 1, OPEN-LABEL, SINGLE
    ASCENDING DOSE STUDY
    S. Cohen1, A. Kivitz2, L. Klassen3, M. Nakazawa4, D. Parenti4, M. DiGiorgi4,
    R. Winston4; 1Metroplex Clinical Res. Ctr., Dallas, TX, 2Altoona Arthritis and
    Osteoporosis Ctr., Duncansville, PA, 3Univ. of Nebraska Med. Ctr., Omaha,
    NE, 4Pacira BioSci.s, Inc., Parsippany, NJ

    O-3
    COMBINATION OF COMPUTATIONAL METHODS
    WITH A DRUG REPURPOSING STRATEGY IDENTIFIES
    A COMPOUND TARGETING CHONDROCYTE
    HYPERTROPHY
    J. Veldman1, M. N. Ferrao Blanco1, N. K. Kops1, K. Sivasubramaniyan1,2,
    J. van Rooij1, E. Farrell1, G. J. van Osch1; 1Erasmus MC, Rotterdam,
    Netherlands, 2Galapagos Nederland, Leiden, Netherlands

Speaker(s):